MESOMesoblast Limited
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−11% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −11% vs its 200-day average.
Lightly shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MESO is trading
Mesoblast Limited is −16% over the past year while the S&P 500 is +18%: 34 points behind the market. Through the fall, its own insiders bought $26M more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −11%
vs 200-day average · a clear downtrend
- RSI (14)
- 38
RSI (14) · neutral
- Below its 52-week high
- 32%
Below its 52-week high
Details›
- Last close2026-10-09
- $14.28
- 1 monthS&P 500 +2.7%
- −7.9%
- 1 yearS&P 500 +18%
- −16%
- 5 yearsS&P 500 +88%
- +12%
- vs 50-day average$15.66
- −8.8%
- 52-week high
- $20.96
- 52-week low
- $13.62
- Annualised volatility
- 74%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $26M
| Year | Return |
|---|---|
| 2026 (year to date) | −21% |
| 2025 | −8.9% |
| 2024 | +800% |
| 2023 | −62% |
| 2022 | −39% |
| 2021 | −43% |
| 2020 | +15% |
| 2019 | +79% |
| 2018 | −29% |
| 2017 | +9.2% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +2.0% |
| Feb | 10 | 4 of 10 | +1.2% |
| Mar | 10 | 4 of 10 | +12% |
| Apr | 10 | 5 of 10 | +19% |
| May | 10 | 5 of 10 | −1.8% |
| Jun | 10 | 3 of 10 | −3.9% |
| Jul | 11 | 6 of 11 | +11% |
| Aug | 11 | 3 of 11 | −3.5% |
| Sep | 11 | 4 of 11 | +2.7% |
| Oct | 11 | 5 of 11 | −4.7% |
| Nov | 10 | 8 of 10 | +9.5% |
| Dec | 10 | 5 of 10 | +0.20% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.